Hormonal
Adopting a flexitarian or semi-vegetarian diet (SVD) is associated with a reduced risk of type 2 diabetes and improved metabolic health markers (glucose, insulin, blood pressure) compared to non-vegetarian diets.
To lower your risk of type 2 diabetes and improve metabolic health, consider a flexitarian diet. This involves eating meat occasionally (e.g., less than once a week) or excluding red meat while eating poultry and fish. Studies show this pattern is associated with lower diabetes prevalence and better blood pressure control compared to standard non-vegetarian diets.
Other research using data from India’s third National Family Health Survey 2005–2006 (n = 156,317) from adults aged 20–49 years found that the consumption of lacto-, lacto-ovo-, and SVDs were associated with a reduced likelihood of diabetes compared with NV diets... With regard to blood pressure, research involving 26 postmenopausal women from convents found that omnivores had significantly higher systolic and diastolic pressures than the SVs.
Why this rating
Based on large observational studies and some RCTs, though definitions of SVD vary.
Source
Flexitarian Diets and Health: A Review of the Evidence-Based Literature
Emma Derbyshire · Frontiers in Nutrition · 2017
DOI 10.3389/fnut.2016.00055
More from this paper
- Adopting a flexitarian or semi-vegetarian diet (SVD) is associated with lower body weight, reduced BMI, and lower body fat percentage compared to non-vegetarian diets.Good
- A high-fiber semi-vegetarian diet may help prevent relapse of symptoms in patients with inflammatory bowel disease (IBD), specifically Crohn's disease.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →